by TractManager | Oct 18, 2021 | Health Technology Assessment
Focus of the Report: This report focuses on Rezūm water vapor therapy for the treatment of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH).Technology Description: Rezūm is a minimally invasive surgical therapy that utilizes the...
by TractManager | Oct 13, 2021 | Health Technology Assessment
Focus of the Report: This health technology assessment focuses on partial knee arthroplasty (PKA) with the Mako Robotic-Arm Assisted Surgery system for treatment of knee osteoarthritis (KOA).Technology Description: The Mako Robotic-Arm system is a semi-active tactile...
by TractManager | Oct 13, 2021 | Health Technology Assessment
Focus of the Report: The focus of this health technology assessment is use of the coflex Interlaminar Stabilization device (Surgalign Spine Technologies Inc.) for the treatment of lumbar spinal stenosis (LSS) in adults. The coflex device offers a minimally invasive...
by TractManager | Oct 11, 2021 | Emerging Technology Report
Tavneos (avacopan) is an oral complement 5a receptor (C5aR) antagonist indicated as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA] and...
by TractManager | Sep 30, 2021 | Precision Medicine Insights
This report reviews clinical study abstracts and clinical practice guidelines addressing genetic testing for facioscapulohumeral muscular dystrophy (FSHD).If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments